{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:35:19Z","timestamp":1784673319925,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.014","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T14:12:24Z","timestamp":1498054344000},"page":"4245-4254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models"],"prefix":"10.1016","volume":"35","author":[{"given":"Hagit","family":"Achdout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Lustig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomer","family":"Israely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Erez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boaz","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Tamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofir","family":"Israeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Waner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Paran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.06.014_b0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(03)00008-1","article-title":"Pathogenesis and potential antiviral therapy of complications of smallpox vaccination","volume":"58","author":"Bray","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.vaccine.2017.06.014_b0010","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/cid\/cir952","article-title":"Eczema vaccinatum","volume":"54","author":"Reed","year":"2012","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2017.06.014_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/A:1026399916888","article-title":"Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity","volume":"27","author":"Becker","year":"2003","journal-title":"Virus Genes."},{"key":"10.1016\/j.vaccine.2017.06.014_b0020","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccinee","volume":"46","author":"Vora","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2017.06.014_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Adverse events. Clin Infect Dis."},{"key":"10.1016\/j.vaccine.2017.06.014_b0030","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jaci.2007.08.004","article-title":"Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation","volume":"120","author":"Scott","year":"2007","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3851\/IMP1717","article-title":"Protective murine and human monoclonal antibodies against eczema vaccinatum","volume":"16","author":"Tomimori","year":"2011","journal-title":"Antivir Ther."},{"key":"10.1016\/j.vaccine.2017.06.014_b0040","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1084\/jem.20082835","article-title":"Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum","volume":"206","author":"Kawakami","year":"2009","journal-title":"J Exp Med."},{"key":"10.1016\/j.vaccine.2017.06.014_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/jid.2008.106","article-title":"Animal models of atopic dermatitis","volume":"129","author":"Jin","year":"2009","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0846.2004.00062.x","article-title":"Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments","volume":"10","author":"Matsumoto","year":"2004","journal-title":"Skin Res Technol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09168451.2014.963500","article-title":"Functional polysaccharides from Grifola frondosa aqueous extract inhibit atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"79","author":"Park","year":"2015","journal-title":"Biosci Biotechnol Biochem."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.06.014_b0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000053599","article-title":"NC\/Nga mice: a mouse model for atopic dermatitis","volume":"120","author":"Suto","year":"1999","journal-title":"Int Arch Allergy Immunol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1357-4310(00)01683-X","article-title":"The NC\/Nga mouse: a model for atopic dermatitis","volume":"6","author":"Vestergaard","year":"2000","journal-title":"Mol Med Today."},{"key":"10.1016\/j.vaccine.2017.06.014_b0070","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1600-0625.2012.01539.x","article-title":"A novel mouse model of atopic dermatitis with epicutaneous allergen sensitization and the effect of Lactobacillus rhamnosus","volume":"21","author":"Kim","year":"2012","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0075","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1743-422X-10-229","article-title":"Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response","volume":"10","author":"Paran","year":"2013","journal-title":"Virol J."},{"key":"10.1016\/j.vaccine.2017.06.014_b0080","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.vaccine.2017.06.014_b0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.virol.2008.10.008","article-title":"Products and substrate\/template usage of vaccinia virus DNA primase","volume":"383","author":"De Silva","year":"2009","journal-title":"Virology."},{"key":"10.1016\/j.vaccine.2017.06.014_b0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/595565","article-title":"Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox","volume":"199","author":"Paran","year":"2009","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2017.06.014_b0095","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.vaccine.2009.01.038","article-title":"Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response","volume":"27","author":"Lustig","year":"2009","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.06.014_b0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jviromet.2005.05.027","article-title":"Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera","volume":"130","author":"Eyal","year":"2005","journal-title":"J Virol Methods."},{"key":"10.1016\/j.vaccine.2017.06.014_b0105","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0110","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/rmv.506","article-title":"Classic paper: Fenner on the exanthemata","volume":"16","author":"Fenner","year":"2006","journal-title":"Rev Med Virol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0115","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.vaccine.2013.03.016","article-title":"Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies","volume":"31","author":"Volz","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.06.014_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.0022-202X.2004.23516.x","article-title":"Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC\/Nga mice in specific-pathogen-free condition","volume":"124","author":"Tomimori","year":"2005","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0125","doi-asserted-by":"crossref","first-page":"e114374","DOI":"10.1371\/journal.pone.0114374","article-title":"Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection","volume":"9","author":"Knitlova","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2017.06.014_b0130","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/jid.2011.409","article-title":"Vaccinia Ig ameliorates eczema vaccinatum in a murine model of atopic dermatitis","volume":"132","author":"Oyoshi","year":"2012","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.vaccine.2017.06.014_b0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMicm010892","article-title":"Images in clinical medicine. Eczema vaccinatum\u2013a timely reminder","volume":"346","author":"Moses","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.vaccine.2017.06.014_b0140","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1016\/j.vaccine.2014.08.022","article-title":"Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis","volume":"32","author":"von Sonnenburg","year":"2014","journal-title":"Vaccine."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T14:59:04Z","timestamp":1535727544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":28,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17307910"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}